| Metric | Q1 2021 | Q4 2020 | Q1 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $133M | — | — | — | — |
| Op. Income | $16M | — | — | — | — |
| Gross Margin | 58.7% | — | — | — | — |
| Net Margin | 7.3% | — | — | — | — |
| EPS (Diluted) | $0.15 | — | — | — | — |
| Free Cash Flow | $18M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $133M |
| Cost of Revenue | $55M |
| GROSS PROFIT | $78M |
| R&D Expenses | $28M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $34M |
| Other Expenses | $0 |
| Operating Expenses | $62M |
| Cost & Expenses | $117M |
| OPERATING INCOME | $16M |
| Interest Income | $0 |
| Interest Expense | $2M |
| Other Income/Expenses | -$5M |
| INCOME BEFORE TAX | $11M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $10M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $10M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $10M |
| D&A | $9M |
| EBIT | $16M |
| EBITDA | $24M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $133M |
| Cost of Revenue | $55M |
| GROSS PROFIT | $78M |
| R&D Expenses | $28M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $34M |
| Other Expenses | $0 |
| Operating Expenses | $62M |
| Cost & Expenses | $117M |
| OPERATING INCOME | $16M |
| Interest Income | $0 |
| Interest Expense | $2M |
| Other Income/Expenses | -$5M |
| INCOME BEFORE TAX | $11M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $10M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $10M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $10M |
| D&A | $9M |
| EBIT | $16M |
| EBITDA | $24M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $10M |
| Depreciation & Amortization | $9M |
| Stock-Based Compensation | $9M |
| Deferred Income Tax | -$184.0K |
| Other Non-Cash Items | $4M |
| Change in Working Capital | -$5M |
| OPERATING CASH FLOW | $26M |
| Capital Expenditure | -$8M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$4M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$4M |
| NET CASH FROM INVESTING | -$12M |
| Net Debt Issuance | -$4M |
| Common Stock Repurchased | -$30M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$6M |
| NET CASH FROM FINANCING | -$39M |
| FREE CASH FLOW | $18M |
| Net Change in Cash | -$24M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $269M |
| Short-Term Investments | $0 |
| Net Receivables | $49M |
| Inventory | $77M |
| Other Current Assets | $23M |
| TOTAL CURRENT ASSETS | $432M |
| PP&E (Net) | $142M |
| Goodwill | $351M |
| Intangible Assets | $17M |
| Long-Term Investments | $465.0K |
| Tax Assets | $21M |
| Other Non-Current Assets | $60M |
| TOTAL NON-CURRENT ASSETS | $591M |
| TOTAL ASSETS | $1.0B |
| Account Payables | $43M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $92M |
| Long-Term Debt | $191M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $4M |
| Other Non-Current Liabilities | $63M |
| TOTAL NON-CURRENT LIABILITIES | $270M |
| TOTAL LIABILITIES | $362M |
| Common Stock | $785.0K |
| Additional Paid-In Capital | $461M |
| Retained Earnings | $621M |
| Treasury Stock | -$414M |
| Accum. Other Comp. Income | -$7M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $661M |
| Minority Interest | $243.0K |
| TOTAL EQUITY | $662M |
| TOTAL LIABILITIES & EQUITY | $1.0B |
| Total Debt | $207M |
| Net Debt | -$62M |
